NCT01949974 Integral Attention Program With or Without Palliative Chemotherapy in Advanced Cancer Patients Status WITHDRAWN Phase PHASE4
NCT01947296 Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents Status COMPLETED Phase N/A
NCT01943864 A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers Status COMPLETED Phase PHASE2
NCT01943409 Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils Status COMPLETED Phase PHASE4
NCT01938443 A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01937533 Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer Status COMPLETED Phase N/A
NCT01931592 Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E Status TERMINATED Phase PHASE2/PHASE3
NCT01926444 A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy Status COMPLETED Phase PHASE2
NCT01919710 Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia Status COMPLETED Phase PHASE1
NCT01915056 A Geriatric Assessment Intervention for Older Cancer Patients Receiving Chemotherapy Status COMPLETED Phase NA
NCT01909856 The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy Status COMPLETED Phase PHASE2
NCT01892046 Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01889511 Text Messaging to Improve Adherence to Oral Chemotherapy Agents Status COMPLETED Phase NA